FTRE
Fortrea Holdings Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -9.8% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 155.91K | $3.15M | n/a | n/a |
| Q2 2026 | 105 | +8 | 74.00M | $1.29B | +12 | −4 |
| Q1 2026 | 100 | -4 | 67.95M | $640.51M | +5 | −9 |
| Q4 2025 | 104 | 0 | 71.13M | $1.23B | +1 | −1 |
| Q3 2025 | 18 | 0 | 53.25M | $448.39M | +2 | −2 |
| Q2 2025 | 15 | +1 | 46.90M | $231.21M | +1 | n/a |
| Q1 2025 | 11 | -2 | 16.99M | $128.27M | +1 | −3 |
| Q4 2024 | 13 | +3 | 14.50M | $270.52M | +4 | −1 |
| Q3 2024 | 9 | -2 | 13.45M | $268.92M | n/a | −2 |
| Q2 2024 | 11 | n/a | 13.76M | $321.15M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 14.19M | -2.9% | $119.48M | 0.0% | ▼ Trim | 2 | SEC ↗ ×12 |
| 2 | The Vanguard Group ✦ (pasivo) | 8.07M | -7.1% | $67.97M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Goldman Sachs Group ✦ | 7.98M | n/a | $67.18M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (pasivo) | 4.07M | -8.2% | $34.28M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 3.74M | -42.7% | $31.45M | 0.0% | ▼ Trim | 6 | SEC ↗ ×6 |
| 6 | Fidelity (FMR) ✦ | 3.05M | -0.6% | $25.70M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 7 | Morgan Stanley ✦ | 2.81M | n/a | $23.64M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 8 | Geode Capital Management ✦ (pasivo) | 2.08M | -4.1% | $17.54M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | JPMorgan Chase ✦ | 1.39M | n/a | $11.67M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 10 | Millennium Management ✦ | 1.35M | -22.3% | $11.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 1.29M | +118.5% | $10.90M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.12M | +4.9% | $9.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 1.08M | +2.2% | $9.08M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 14 | Citadel Advisors ✦ | 609.41K | +309.1% | $5.13M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | Arrowstreet Capital ✦ | 130.94K | Nuevo | $1.10M | 0.0% | New | 1 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 117.50K | Nuevo | $989,349 | 0.0% | New | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 92.47K | +16.8% | $779,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Marshall Wace ✦ | 79.73K | -59.0% | $671,361 | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Arrowstreet Capital | $1.10M | 0.0% |
| Point72 Asset Management | $989,349 | 0.0% |
Posición cerrada
| Starboard Value | $12.33M | era 0.2% |
| Gotham Asset Management | $137,268 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 327 tenedores, 98.96M acciones, $906.93M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 3.15K acc. · $53,061
Officer · 246 acc. · $4,145
Officer · 4.89K acc. · $88,985
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología